Intermucol

Carbocisteine, the active ingredient in Intermucol, is a mucolytic agent presented as an oral formulation for oral use. It reduces the thickness of mucus and aids clearance in patients with chronic respiratory conditions such as chronic bronchitis, COPD, and bronchiectasis.

GNH USA supplies Intermucol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions. Its distribution network ensures timely delivery and regulatory compliance for each order.

Carbocisteine is used as a mucolytic to improve mucus clearance in chronic respiratory diseases.

- Chronic bronchitis: helps reduce sputum viscosity and facilitates expectoration. - Chronic obstructive pulmonary disease (COPD): assists in clearing airway secretions, improving breathing comfort. - Bronchiectasis: aids in thinning mucus, supporting airway hygiene.

Carbocisteine may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea - Diarrhea - Abdominal discomfort - Headache

Serious or Rare Side Effects: - Allergic skin reactions (rash, urticaria, angioedema) - Severe gastrointestinal upset (vomiting, intense abdominal pain) - Anaphylaxis (rare but potentially life‑threatening)

Before initiating therapy, consider the following precautions.

- Renal function assessment: evaluate kidney status in patients with renal impairment. - Hypersensitivity monitoring: watch for signs of allergic reaction during treatment. - Peptic ulcer disease: use with caution in patients with active ulcers. - Known carbocisteine allergy: avoid in individuals with documented hypersensitivity. - Duration of use: do not exceed the prescriber‑recommended treatment period. - Store at room temperature: keep in the original pack, protect from moisture.

Carbocisteine may interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - Concomitant use with antitussive agents that suppress cough, as mucus clearance may be impaired.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may increase the frequency of cough. - Anticoagulants: potential for increased gastrointestinal bleeding. - Other mucolytics: may amplify gastrointestinal side effects. - Alcohol: can worsen gastrointestinal discomfort.